Stock Information

Stock Quote

(Common Stock)
(US Dollars)
Change
Exchange (%)	(US Dollar)
Intraday High
Intraday Low
Volume
Today's Open
Previous Close
52 Week High
52 Week Low
Data as of

About us

Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Our pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response.

Investor Relations Contacts

Stock Information

Stock Quote

About us

Our Pipeline